口服避孕药(OCP)在辅助生殖技术(ART)中有着广泛的应用,但是不同的学者的研究结果不一。多数研究认为,OCP可以改善体外受精的妊娠结局。在助孕周期前应用OCP预处理,可以计划性安排治疗时机、改善卵巢反应性、提高妊娠率、降低周期取消率、预防卵巢过度刺激综合征(OHSS)以及功能性卵巢囊肿等并发症的发生。 OCP is widely used in assisted reproductive technology (ART), but different scholars have different results. Most studies suggest that OCP can improve the pregnancy outcome of in vitro fertilization. Applying OCP preconditioning before the gestation period can plan the timing of treatment, improve ovarian response, improve pregnancy rate, reduce cycle cancellation rate, prevent ovarian hyperstimulation syndrome (OHSS) and functional ovarian cyst and other complications .